Experts caution those using these services to be careful, as you may not always get what you want from biological relatives.

Forbes contributors publish independent expert analyses and insights. Matthew F. Erskine is a trusts and estates attorney. Imagine opening a birthday gift DNA kit and discovering you're entitled to ...

Major Scientific Expansion Provides the Most Detailed Look at African Ancestry on the Market, Helping to Bypass Historical 'Brick Walls' for Individuals with African Heritage PALO ALTO, Calif., Nov.

PALO ALTO, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- For millions of Americans in the African diaspora, genealogical ties and records were severed by the transatlantic slave trade, creating a 'brick ...

PALO ALTO, Calif. - November 20, 2025 - For millions of Americans in the African diaspora, genealogical ties and records were severed by the transatlantic slave trade, creating a "brick wall" for ...

A major collaboration between UC San Diego and 23andMe identified genes that shape cannabis use behaviors. The study linked the CADM2 and GRM3 genes to cannabis use and connected these patterns to ...

It's estimated that nearly 30% of people who try cannabis will go on to develop a substance use disorder associated with it. Strong predictors include how often a person uses it, and whether they have ...

Today is the deadline for customers of the genetic testing company 23andMe to file a claim as part of a restructuring in its bankruptcy case. In filing a claim, eligible customers can seek ...

Investigators started work to determine what happened to a Logan couple whose bodies were found along the Logan River less than a day after they were reported m Family in Draper questions police ...

Wojcicki launched TTAM earlier this year with the specific goal of keeping 23andMe’s genetic data of about 15 million users out of the hands of third parties like biotech firm Regeneron, which bid ...

The prospect of 23andMe’s trove of genetic information on millions of people passing to the highest bidder had sparked outcry when it was announced in May that New York-based Regeneron Pharmaceuticals ...